FONR
FONAR Corporation
NASDAQ · Healthcare · Medical - Devices · US
$19.09
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 105.3M | 104.4M | 102.9M | 98.6M | 97.6M |
| Cost of Revenue | 62.9M | 61.4M | 57.7M | 52.9M | 50.6M |
| Gross Profit | 42.4M | 42.9M | 45.1M | 45.7M | 47.0M |
| Operating Expenses | |||||
| R&D Expense | 1.8M | 1.6M | 1.7M | 1.6M | 1.5M |
| SG&A Expense | 21.4M | 29.7M | — | 29.4M | — |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 9.7M | — | 26.9M | — | 23.5M |
| Total Operating Expenses | 32.9M | 31.3M | 28.6M | 31.0M | 25.0M |
| Cost and Expenses | 95.8M | 92.8M | 86.3M | 83.9M | 75.6M |
| Operating Income (EBIT) | 9.5M | 11.6M | 16.5M | 14.8M | 22.0M |
| Non-Operating | |||||
| Interest Income | 1.8M | 2.2M | — | — | — |
| Interest Expense | 12.6K | 25.6K | 77.0K | 50.1K | 346.6K |
| Net Interest Income | 1.8M | 2.1M | (77.0K) | (50.1K) | (346.6K) |
| Other Non-Op Income/Expense | 1.8M | 2.2M | 2.7M | 969.3K | 761.7K |
| Non-Operating Income (excl Interest) | (1.9M) | (2.2M) | (2.8M) | (1.0M) | (1.1M) |
| EBT (Pre-Tax Income) | 11.4M | 13.8M | 19.3M | 15.8M | 22.8M |
| Income Tax Expense | 2.5M | 3.1M | 5.2M | 3.6M | 5.5M |
| Bottom Line | |||||
| Net Income | 6.7M | 8.3M | 10.6M | 9.4M | 12.4M |
| Earnings from Cont. Ops | 8.9M | 10.7M | 14.1M | 12.1M | 17.2M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 6.4M | 7.9M | 10.1M | 8.9M | 11.9M |
| Per Share | |||||
| Basic EPS | $1.01 | $1.26 | $1.56 | $1.35 | $1.78 |
| Diluted EPS | $1.00 | $1.23 | $1.53 | $1.32 | $1.75 |
| Revenue Per Share | $17.08 | $16.52 | $16.20 | $14.84 | $14.89 |
| Shares | |||||
| Basic Shares Outstanding | 6.2M | 6.3M | 6.4M | 6.6M | 6.6M |
| Diluted Shares Outstanding | 6.3M | 6.6M | 6.5M | 6.8M | 6.7M |
| Profitability Metrics | |||||
| EBITDA | 15.9M | 18.5M | 23.9M | 24.6M | 27.7M |
| D&A | 4.5M | 4.7M | 4.6M | 8.8M | 4.5M |
| EBIT | 11.4M | 13.8M | 19.3M | 15.8M | 23.1M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026